Affymax, Inc. Stock Nasdaq
Equities
US00826A1097
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2012 | 94.37M 128M | Sales 2013 | 1.37M 1.86M | Capitalization | 29.24M 39.78M |
---|---|---|---|---|---|
Net income 2012 | -93M -127M | Net income 2013 | -14M -19.04M | EV / Sales 2012 | 6.75 x |
Net cash position 2012 | 69.14M 94.04M | Net cash position 2013 | 5.6M 7.61M | EV / Sales 2013 | 17.3 x |
P/E ratio 2012 |
-7.39
x | P/E ratio 2013 |
-2.03
x | Employees | - |
Yield 2012 * |
-
| Yield 2013 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |